WWTR1 (Q9GZV5) variants and mutations
WWTR1 (also known as Q9GZV5) is a human protein-coding gene encoding a WW domain-containing transcription regulator protein 1 protein. When Hippo signaling and mechanical cues permit nuclear accumulation, it promotes growth, survival, and lineage-specific gene programs when nuclear. Persistent activation supports tumor progression, and oncogenic WWTR1 fusions define selected soft-tissue tumors. This analysis covers 672 WWTR1 variants and mutations. Of these, 76% have computational variant effect predictions. Disease context includes gastric carcinoma, esophageal adenocarcinoma, and pancreatic ductal adenocarcinoma. Example WWTR1 variants include M1?, N2H, and P3A.
Variant analysis overview
- Gene: WWTR1
- Protein: Q9GZV5
- UniProt accession: Q9GZV5
- Organism: Homo sapiens
- Variants analyzed: 672
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 497 unspecified-consequence records; 77 synonymous variants; 76 missense variants; 9 frameshift variants; 1 protein altering variant; 3 stop-gained variants; 3 splice-region variants; 5 in-frame deletions; 1 in-frame insertions
- Prediction scores: 510 variants have prediction scores (76% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: gastric carcinoma, esophageal adenocarcinoma, pancreatic ductal adenocarcinoma, breast ductal adenocarcinoma, prostate adenocarcinoma, pancreatic neuroendocrine tumor, neurodegenerative disease, skin carcinoma, kidney neoplasm, carcinoma of liver and intrahepatic biliary tract, ovarian endometrioid adenocarcinoma with squamous differentiation, bile duct carcinoma.
Protein structure and variant hotspots
- Protein features: 1 domains; 5 post-translational modification sites.
- Structural context: 42 variants have structural context.
- PTM context: 12 variants overlap post-translational modification sites.
- Experimental data: 47 protein positions have experimental scores. Source: WWTR1 WW domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable WWTR1 variants
Examples include M1?, N2H, P3A, P3L, A4T, A4V, A6P, A6V. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, cosmic curated COSV10064
- N2H (p.Asn2His), cosmic curated COSV62290
- P3A (p.Pro3Ala), Ensembl rs1560107298
- P3L (p.Pro3Leu), TOPMed rs1257077313, gnomAD rs1257077313, REVEL 0.18, CADD 26.30
- A4T (p.Ala4Thr), TOPMed rs1713301106, gnomAD rs1713301106, REVEL 0.09, CADD 22.80
- A4V (p.Ala4Val), TOPMed rs1360136011
- A6P (p.Ala6Pro), rs1380311710, ClinGen CA354929038, ClinVar RCV003437968, TOPMed rs1380311710, REVEL 0.10, CADD 23.80, Uncertain significance, not provided
- A6V (p.Ala6Val), gnomAD rs1281572654
- P7S (p.Pro7Ser), cosmic curated COSV10442
- P8H (p.Pro8His), ExAC rs775931257, TOPMed rs775931257, gnomAD rs775931257, REVEL 0.05, CADD 21.50
- P8R (p.Pro8Arg), ExAC rs775931257, TOPMed rs775931257, gnomAD rs775931257, REVEL 0.03, CADD 22.20
- P8T (p.Pro8Thr), rs2472811184, ClinGen CA354929027, ClinVar RCV004286983, Uncertain significance, not specified
- P9L (p.Pro9Leu), rs149985695, ClinGen CA2662450, cosmic curated COSV10652, ClinVar RCV003437967, REVEL 0.11, CADD 22.60, Uncertain significance, not provided
- P9Q (p.Pro9Gln), 1000Genomes rs149985695, ESP rs149985695, ExAC rs149985695, TOPMed rs149985695, REVEL 0.09, CADD 22.90, Uncertain significance
- P9S (p.Pro9Ser), TOPMed rs921827996, gnomAD rs921827996, REVEL 0.05, CADD 19.90
- P9T (p.Pro9Thr), TOPMed rs921827996, gnomAD rs921827996, REVEL 0.06, CADD 18.70
- P11L (p.Pro11Leu), cosmic curated COSV10064, gnomAD rs1435169768, REVEL 0.17, CADD 24.40
- P11T (p.Pro11Thr), cosmic curated COSV10064
- P12L (p.Pro12Leu), rs1330547066, TOPMed rs1330547066, gnomAD rs1330547066, REVEL 0.21, CADD 25.60, Variant assessed as somatic; moderate impact.
- G14E (p.Gly14Glu), Ensembl rs1713297821
- G14W (p.Gly14Trp), gnomAD rs1320220699, REVEL 0.39, CADD 31.00
- Q15H (p.Gln15His), ExAC rs779611911, gnomAD rs779611911, REVEL 0.06, CADD 19.80
- V17A (p.Val17Ala), Ensembl rs1208826284
- V17L (p.Val17Leu), TOPMed rs963468962, gnomAD rs963468962, REVEL 0.11, CADD 23.90
- V17M (p.Val17Met), rs963468962, TOPMed rs963468962, gnomAD rs963468962, REVEL 0.17, CADD 27.00, Variant assessed as somatic; moderate impact.
- I18V (p.Ile18Val), ExAC rs757327711, TOPMed rs757327711, gnomAD rs757327711, REVEL 0.07, CADD 20.40
- L24V (p.Leu24Val), ESP rs368881113, ExAC rs368881113, TOPMed rs368881113, gnomAD rs368881113, REVEL 0.12, CADD 23.60
- T26A (p.Thr26Ala), gnomAD rs1243863570, REVEL 0.15, CADD 24.80
- D27H (p.Asp27His), TOPMed rs1193262000
- D27Y (p.Asp27Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L28F (p.Leu28Phe), TOPMed rs1713294616
- E29K (p.Glu29Lys), cosmic curated COSV62292
- E29Q (p.Glu29Gln), TOPMed rs1713294121
- A30V (p.Ala30Val), Ensembl rs1713293924, REVEL 0.33, CADD 29.60
- N33D (p.Asn33Asp), TOPMed rs1268544546, gnomAD rs1268544546, REVEL 0.11, CADD 24.00
- N33I (p.Asn33Ile), TOPMed rs1480331695, gnomAD rs1480331695, REVEL 0.29, CADD 28.20
- S34P (p.Ser34Pro), ExAC rs767255084, gnomAD rs767255084, Uncertain significance, not specified
- S34Y (p.Ser34Tyr), cosmic curated COSV62291
- M36L (p.Met36Leu), ExAC rs766298507, gnomAD rs766298507, REVEL 0.14, CADD 22.10
- S42L (p.Ser42Leu), gnomAD rs1339640647, REVEL 0.17, CADD 25.70
- W43C (p.Trp43Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- R44L (p.Arg44Leu), rs762511917, NCI-TCGA Cosmic COSV6229, cosmic curated COSV62293, ExAC rs762511917, REVEL 0.43, CADD 29.20, Variant assessed as somatic; moderate impact.
- I47N (p.Ile47Asn), gnomAD rs1339816163, REVEL 0.10, CADD 23.10
- L48R (p.Leu48Arg), cosmic curated COSV62293
- P49L (p.Pro49Leu), gnomAD rs1373324254, REVEL 0.58, CADD 32.00
- E50Q (p.Glu50Gln), NCI-TCGA TCGA novel, REVEL 0.07, CADD 24.00, Variant assessed as somatic; moderate impact.
- F52L (p.Phe52Leu), NCI-TCGA TCGA novel, REVEL 0.27, CADD 27.60, Variant assessed as somatic; moderate impact.
- K54E (p.Lys54Glu), NCI-TCGA Cosmic COSV6229, cosmic curated COSV62290, Variant assessed as somatic; moderate impact.
- E55K (p.Glu55Lys), NCI-TCGA TCGA novel, REVEL 0.10, CADD 25.40, Variant assessed as somatic; moderate impact.
- P56H (p.Pro56His), gnomAD rs1421872616, REVEL 0.36, CADD 28.80
- P56S (p.Pro56Ser), gnomAD rs1410805074
- S58L (p.Ser58Leu), Ensembl rs1576627460, REVEL 0.17, CADD 31.00
- G59S (p.Gly59Ser), TOPMed rs1477506447, gnomAD rs1477506447, REVEL 0.13, CADD 24.70
- S60L (p.Ser60Leu), ExAC rs772542532, TOPMed rs772542532, gnomAD rs772542532, REVEL 0.15, CADD 25.20, Uncertain significance, not specified
- H61L (p.His61Leu), gnomAD rs1402893555, REVEL 0.42, CADD 28.90
- H61Y (p.His61Tyr), gnomAD rs1237323031, REVEL 0.36, CADD 27.70
- S62L (p.Ser62Leu), cosmic curated COSV62292, REVEL 0.45, CADD 32.00
- S62P (p.Ser62Pro), TOPMed rs1404133951, REVEL 0.34, CADD 29.10
- S62W (p.Ser62Trp), NCI-TCGA Cosmic COSV6229, REVEL 0.59, CADD 32.00, Variant assessed as somatic; moderate impact.
- R63C (p.Arg63Cys), cosmic curated COSV62292, Ensembl rs1025385597, REVEL 0.31, CADD 31.00
- R63L (p.Arg63Leu), gnomAD rs1427667024, REVEL 0.25, CADD 29.90
- S66G (p.Ser66Gly), rs2472810232, ClinGen CA354928410, ClinVar RCV004309872, REVEL 0.24, CADD 29.80, Uncertain significance, not specified
- T67A (p.Thr67Ala), gnomAD rs1193595953
- T67I (p.Thr67Ile), gnomAD rs1012537922, REVEL 0.13, CADD 29.40
- D68N (p.Asp68Asn), cosmic curated COSV10525, REVEL 0.16, CADD 31.00
- S70L (p.Ser70Leu), TOPMed rs1713284360, REVEL 0.11, CADD 29.90
- G72A (p.Gly72Ala), gnomAD rs1235003169, REVEL 0.08, CADD 24.00
- G72S (p.Gly72Ser), TOPMed rs1223849448, gnomAD rs1223849448, REVEL 0.04, CADD 21.40
- P74Q (p.Pro74Gln), cosmic curated COSV62290, 1000Genomes rs1055153, ESP rs1055153, ExAC rs1055153, REVEL 0.10, CADD 25.70
- P74R (p.Pro74Arg), 1000Genomes rs1055153, ESP rs1055153, ExAC rs1055153, TOPMed rs1055153, REVEL 0.14, CADD 25.80
- P74T (p.Pro74Thr), Ensembl rs1713283230, REVEL 0.12, CADD 23.80
- G75R (p.Gly75Arg), ExAC rs771394606, TOPMed rs771394606, gnomAD rs771394606, REVEL 0.05, CADD 23.20
- G75V (p.Gly75Val), TOPMed rs1713282358, REVEL 0.10, CADD 24.00, Uncertain significance, not specified
- R77Q (p.Arg77Gln), Ensembl rs2108164556
- A79D (p.Ala79Asp), TOPMed rs1000960963, gnomAD rs1000960963, REVEL 0.08, CADD 23.80
- A79P (p.Ala79Pro), ExAC rs756242761, TOPMed rs756242761, gnomAD rs756242761, REVEL 0.07, CADD 19.40, Uncertain significance, not specified
- A79S (p.Ala79Ser), cosmic curated COSV62290, ExAC rs756242761, TOPMed rs756242761, gnomAD rs756242761, REVEL 0.03, CADD 16.70
- A79T (p.Ala79Thr), ExAC rs756242761, TOPMed rs756242761, gnomAD rs756242761, REVEL 0.03, CADD 20.20
- G80A (p.Gly80Ala), gnomAD rs1167173581, REVEL 0.03, CADD 12.90
- G80R (p.Gly80Arg), Ensembl rs1713281227, REVEL 0.07, CADD 12.80
- G81R (p.Gly81Arg), cosmic curated COSV62291
- G81S (p.Gly81Ser), gnomAD rs1474550521
- G81V (p.Gly81Val), TOPMed rs1257569098, gnomAD rs1257569098, REVEL 0.06, CADD 22.00
- A82V (p.Ala82Val), cosmic curated COSV62293, gnomAD rs1178190673, REVEL 0.11, CADD 22.70
- Q83L (p.Gln83Leu), cosmic curated COSV62291
- H84D (p.His84Asp), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10064, Variant assessed as somatic; moderate impact.
- H84R (p.His84Arg), cosmic curated COSV10820
- V85A (p.Val85Ala), Ensembl rs1713279473, REVEL 0.11, CADD 22.90, Uncertain significance, not specified
- V85D (p.Val85Asp), Ensembl rs1713279473, Uncertain significance
- V85L (p.Val85Leu), TOPMed rs1197717753, gnomAD rs1197717753, REVEL 0.07, CADD 23.40
- R86C (p.Arg86Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S89A (p.Ser89Ala), cosmic curated COSV62291
- S89L (p.Ser89Leu), NCI-TCGA Cosmic COSV1006, Variant assessed as somatic; moderate impact.
- S89T (p.Ser89Thr), cosmic curated COSV62291
- S89W (p.Ser89Trp), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10064, Variant assessed as somatic; moderate impact.
- S90P (p.Ser90Pro), NCI-TCGA Cosmic COSV6229, cosmic curated COSV62290, Variant assessed as somatic; moderate impact.
- S90T (p.Ser90Thr), gnomAD rs1273337367, REVEL 0.24, CADD 29.30
- P91H (p.Pro91His), cosmic curated COSV62291, REVEL 0.50, CADD 32.00
- P91L (p.Pro91Leu), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10064, NCI-TCGA Cosmic COSV6229, Variant assessed as somatic; moderate impact.
- P91S (p.Pro91Ser), NCI-TCGA TCGA novel, REVEL 0.42, CADD 26.50, Variant assessed as somatic; moderate impact.
- A92S (p.Ala92Ser), TOPMed rs1713277666, REVEL 0.24, CADD 27.90
- S93F (p.Ser93Phe), Ensembl rs1713277213, REVEL 0.36, CADD 32.00
- Q95R (p.Gln95Arg), Ensembl rs945788619
- G97A (p.Gly97Ala), ExAC rs761456916, TOPMed rs761456916, gnomAD rs761456916, Uncertain significance
- G97D (p.Gly97Asp), rs761456916, ClinGen CA85576366, ClinVar RCV004137667, ExAC rs761456916, REVEL 0.06, CADD 22.60, Uncertain significance, not specified
- G97S (p.Gly97Ser), gnomAD rs1446392512, REVEL 0.09, CADD 23.40
- G99R (p.Gly99Arg), TOPMed rs1459922346, gnomAD rs1459922346, REVEL 0.03, CADD 18.80
- G99S (p.Gly99Ser), TOPMed rs1459922346, gnomAD rs1459922346, REVEL 0.03, CADD 16.60, Uncertain significance, not specified
- A100T (p.Ala100Thr), rs763906518, ExAC rs763906518, gnomAD rs763906518, REVEL 0.07, CADD 15.70, Variant assessed as somatic; moderate impact.
- G101V (p.Gly101Val), ExAC rs774517756, TOPMed rs774517756, gnomAD rs774517756, REVEL 0.13, CADD 21.70
- A102V (p.Ala102Val), ExAC rs771327704, TOPMed rs771327704, gnomAD rs771327704, REVEL 0.04, CADD 19.30
- A103E (p.Ala103Glu), 1000Genomes rs769836377, ExAC rs769836377, TOPMed rs769836377, gnomAD rs769836377, REVEL 0.06, CADD 22.70, Uncertain significance, not specified
- A103G (p.Ala103Gly), 1000Genomes rs769836377, ExAC rs769836377, TOPMed rs769836377, gnomAD rs769836377, REVEL 0.07, CADD 20.60
- A103T (p.Ala103Thr), ExAC rs763327005, TOPMed rs763327005, gnomAD rs763327005, REVEL 0.06, CADD 12.50, Uncertain significance, not specified
- A103V (p.Ala103Val), 1000Genomes rs769836377, ExAC rs769836377, TOPMed rs769836377, gnomAD rs769836377, REVEL 0.05, CADD 20.60, Uncertain significance, not specified
- G104A (p.Gly104Ala), cosmic curated COSV10943, 1000Genomes rs201754525, ExAC rs201754525, TOPMed rs201754525, REVEL 0.09, CADD 0.20
- G104D (p.Gly104Asp), 1000Genomes rs201754525, ExAC rs201754525, TOPMed rs201754525, gnomAD rs201754525, REVEL 0.10, CADD 2.99, Uncertain significance, not specified
- G104S (p.Gly104Ser), gnomAD rs1487193626, REVEL 0.05, CADD 9.35
- S105G (p.Ser105Gly), 1000Genomes rs566092490, ExAC rs566092490, gnomAD rs566092490, REVEL 0.06, CADD 21.90
- S105I (p.Ser105Ile), TOPMed rs1318641028, gnomAD rs1318641028, REVEL 0.11, CADD 23.10
- P106A (p.Pro106Ala), ExAC rs758233563, TOPMed rs758233563, gnomAD rs758233563, REVEL 0.06, CADD 14.40, Uncertain significance
- P106L (p.Pro106Leu), Ensembl rs1713271328, REVEL 0.06, CADD 22.60
- P106S (p.Pro106Ser), rs758233563, ClinGen CA2662404, ClinVar RCV004483328, ExAC rs758233563, REVEL 0.04, CADD 15.80, Uncertain significance, not specified
- A107E (p.Ala107Glu), Ensembl rs1713270766, REVEL 0.10, CADD 24.40
- Q109* (p.Gln109Ter), cosmic curated COSV10747, CADD 38.00
- Q109H (p.Gln109His), ExAC rs756822799, gnomAD rs756822799, REVEL 0.13, CADD 23.00
- H110N (p.His110Asn), Ensembl rs1713269794, REVEL 0.17, CADD 25.40
- H110Q (p.His110Gln), TOPMed rs1713269475, gnomAD rs1713269475, REVEL 0.15, CADD 23.10
- A111E (p.Ala111Glu), ESP rs372365663, ExAC rs372365663, TOPMed rs372365663, gnomAD rs372365663, REVEL 0.11, CADD 22.40
- A111V (p.Ala111Val), cosmic curated COSV10064, REVEL 0.06, CADD 22.80
- H112Y (p.His112Tyr), gnomAD rs1433577819, REVEL 0.32, CADD 31.00
- R114C (p.Arg114Cys), cosmic curated COSV62292, REVEL 0.26, CADD 26.90
- R114H (p.Arg114His), cosmic curated COSV62291, REVEL 0.12, CADD 25.10
- Q115H (p.Gln115His), cosmic curated COSV10064, REVEL 0.26, CADD 25.00
- Q116K (p.Gln116Lys), gnomAD rs1295140730, REVEL 0.11, CADD 20.90
- Q116R (p.Gln116Arg), rs763707772, ClinGen CA2662399, ClinVar RCV003437966, ExAC rs763707772, REVEL 0.04, CADD 20.00, Uncertain significance, not provided
- D119G (p.Asp119Gly), cosmic curated COSV62291
- D119N (p.Asp119Asn), cosmic curated COSV10820, REVEL 0.20, CADD 25.60
- V120E (p.Val120Glu), TOPMed rs1443075270
- V120M (p.Val120Met), cosmic curated COSV62292, gnomAD rs1435671374, REVEL 0.02, CADD 23.20
- T121I (p.Thr121Ile), ExAC rs766632650, TOPMed rs766632650, gnomAD rs766632650, REVEL 0.09, CADD 23.60
- T121K (p.Thr121Lys), cosmic curated COSV10970
- T121N (p.Thr121Asn), ExAC rs766632650, TOPMed rs766632650, gnomAD rs766632650, REVEL 0.09, CADD 24.60
- D122E (p.Asp122Glu), gnomAD rs963230590, REVEL 0.10, CADD 18.40
- D122N (p.Asp122Asn), NCI-TCGA Cosmic COSV1006, cosmic curated COSV10064, REVEL 0.20, CADD 25.50, Variant assessed as somatic; moderate impact.
- E123K (p.Glu123Lys), cosmic curated COSV10652, ExAC rs763418690, TOPMed rs763418690, gnomAD rs763418690, REVEL 0.20, CADD 31.00
- E123Q (p.Glu123Gln), rs763418690, NCI-TCGA Cosmic COSV6229, cosmic curated COSV62291, ExAC rs763418690, REVEL 0.13, CADD 28.90, Variant assessed as somatic; moderate impact.
- L124M (p.Leu124Met), cosmic curated COSV10064, Ensembl rs907694880, REVEL 0.03, CADD 22.60
- P125T (p.Pro125Thr), gnomAD rs1186585667, REVEL 0.65, CADD 31.00
- P127L (p.Pro127Leu), ExAC rs770347565, gnomAD rs770347565, REVEL 0.92, CADD 32.00
- P127S (p.Pro127Ser), ExAC rs773592492, gnomAD rs773592492, REVEL 0.90, CADD 32.00
- P128R (p.Pro128Arg), gnomAD rs1215659914, REVEL 0.74, CADD 26.60
- G129D (p.Gly129Asp), TOPMed rs1713261188, gnomAD rs1713261188, REVEL 0.94, CADD 29.90
- E131D (p.Glu131Asp), gnomAD rs1282745884, REVEL 0.82, CADD 27.70
- M132I (p.Met132Ile), NCI-TCGA TCGA novel, REVEL 0.56, CADD 26.40, Variant assessed as somatic; moderate impact.
- T133I (p.Thr133Ile), gnomAD rs1231267072, REVEL 0.43, CADD 25.50
- F134L (p.Phe134Leu), TOPMed rs1388207214, gnomAD rs1388207214, REVEL 0.21, CADD 20.50
- F134S (p.Phe134Ser), gnomAD rs1311819435, REVEL 0.32, CADD 23.10
- T135M (p.Thr135Met), ExAC rs762322089, gnomAD rs762322089, REVEL 0.93, CADD 32.00
- A136D (p.Ala136Asp), cosmic curated COSV10943, REVEL 0.24, CADD 22.70
- A136T (p.Ala136Thr), NCI-TCGA TCGA novel, REVEL 0.21, CADD 19.40, Variant assessed as somatic; moderate impact.
- T137A (p.Thr137Ala), TOPMed rs1713259531
- T137I (p.Thr137Ile), cosmic curated COSV10525, REVEL 0.55, CADD 27.00
- G138R (p.Gly138Arg), Ensembl rs1678629174, REVEL 0.97, CADD 32.00
- Q139H (p.Gln139His), TOPMed rs1449575136, gnomAD rs1449575136, REVEL 0.87, CADD 31.00
- Q139P (p.Gln139Pro), gnomAD rs1458039499, REVEL 0.96, CADD 32.00
- R140K (p.Arg140Lys), ExAC rs747164910, TOPMed rs747164910, gnomAD rs747164910, REVEL 0.26, CADD 22.40
- R140M (p.Arg140Met), NCI-TCGA TCGA novel, REVEL 0.64, CADD 25.80, Variant assessed as somatic; moderate impact.
- Y141D (p.Tyr141Asp), gnomAD rs1377588889
- Y141N (p.Tyr141Asn), gnomAD rs1377588889, REVEL 0.98, CADD 32.00
- F142C (p.Phe142Cys), cosmic curated COSV10467
- F142V (p.Phe142Val), ExAC rs747153038, gnomAD rs747153038, REVEL 0.96, CADD 33.00
- L143F (p.Leu143Phe), cosmic curated COSV62291, REVEL 0.68, CADD 29.60
- N144S (p.Asn144Ser), gnomAD rs1376684329, REVEL 0.64, CADD 23.50
- I146M (p.Ile146Met), rs764139095, ClinGen CA2662370, ClinVar RCV004164271, ExAC rs764139095, REVEL 0.51, CADD 24.80, Uncertain significance, not specified
- I146R (p.Ile146Arg), ExAC rs777145948, TOPMed rs777145948, gnomAD rs777145948
- I146T (p.Ile146Thr), ExAC rs777145948, TOPMed rs777145948, gnomAD rs777145948, REVEL 0.36, CADD 23.30
- I146V (p.Ile146Val), TOPMed rs1307281483, gnomAD rs1307281483
- K148N (p.Lys148Asn), cosmic curated COSV62292
- I149S (p.Ile149Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
Public WWTR1 analysis runs
- WWTR1 analysis run — WWTR1 (672 variants) — completed 2026-08-19